Protagonist Therapeutics股价周五上午大涨约9%,此前有媒体报道称这家生物制药公司正在与强生就可能的收购交易进行谈判。
该消息引发了市场对这笔潜在并购交易的关注,推动Protagonist Therapeutics股价出现显著上涨。
Protagonist Therapeutics股价周五上午大涨约9%,此前有媒体报道称这家生物制药公司正在与强生就可能的收购交易进行谈判。
该消息引发了市场对这笔潜在并购交易的关注,推动Protagonist Therapeutics股价出现显著上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.